Brookfield Corp’s Aspen Aerogels ASPN Stock Holding History

Brookfield Corp’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,020	Closed	-$499K	–	620
2021 Q4	$499K	Buy	+10,020	New	+$528K	﹤0.01%	540

Other funds holding ASPN

SCC

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brookfield Corp's ASPN Position: Q1 2022 in Review

Brookfield Corp sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 10,020 shares — an estimated $499K sold.

Brookfield Corp first reported a position in ASPN in Q4 2021 and held it in 1 quarter. The position peaked at $499K in Q4 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

Brookfield Corp reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
Brookfield Corp sold 10,020 Aspen Aerogels shares in Q1 2022, an estimated $499K.
Brookfield Corp first reported a position in Aspen Aerogels in Q4 2021 and held it in 1 quarter.
Brookfield Corp's Aspen Aerogels position peaked at $499K in Q4 2021.
145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.